Ashwagandha (Withania somnifera) may potentially modulate neurological symptoms in Visual Snow Syndrome through its adaptogenic and neuroprotective properties, primarily by reducing oxidative stress and modulating GABA and glutamate neurotransmitter systems. Its active withanolides demonstrate anxiolytic and anti-inflammatory effects that could help mitigate neurological hyperexcitability and sensory processing abnormalities associated with the syndrome.